Insider · CIK 0001704336

Cloonan Michael

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001704336

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-17	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director, President & CEO	AAward	+436K sh	—	—	436,100
2026-09-17	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−436K sh	—	—	0
2026-09-17	SIONSionna Therapeutics, Inc.A Award	Director, President & CEO	AAward	+109K sh	—	—	765,393
2026-09-17	SIONSionna Therapeutics, Inc.A Award	Director, President & CEO	AAward	+109K sh	—	—	656,368
2026-01-02	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director, President & CEO	AAward	+436K sh	—	—	436,100
2025-10-21	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−30K sh	—	—	109,569
2025-10-21	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−22.9K sh	—	—	86,674
2025-10-21	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−33.5K sh	—	—	53,142
2025-10-21	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−30K sh	$35.63	−$1.07M	547,343
2025-10-21	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+22.9K sh	$6.11	+$140K	570,238
2025-10-21	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−22.9K sh	$36.60	−$838K	547,343
2025-10-21	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+33.5K sh	$6.11	+$205K	580,875
2025-10-21	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−33.5K sh	$37.31	−$1.25M	547,343
2025-10-21	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−13.3K sh	—	—	139,618
2025-10-21	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+13.3K sh	$6.11	+$81.4K	560,667
2025-10-21	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−13.3K sh	$34.44	−$459K	547,343
2025-10-21	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+30K sh	$6.11	+$184K	577,392
2025-10-16	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−10.2K sh	—	—	153,142
2025-10-16	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−200 sh	$34.00	−$6,800	547,343
2025-10-16	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+200 sh	$6.11	+$1,222	547,543
2025-10-16	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−10.2K sh	$31.46	−$322K	547,343
2025-10-16	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10.2K sh	$6.11	+$62.5K	557,568
2025-10-16	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−200 sh	—	—	152,942
2025-10-15	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−14.8K sh	$31.11	−$460K	547,343
2025-10-15	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−14.8K sh	—	—	163,367
2025-10-15	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+14.8K sh	$6.11	+$90.3K	562,118
2025-09-29	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−7,793 sh	—	—	178,142
2025-09-29	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+7,793 sh	$6.11	+$47.6K	555,136
2025-09-29	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−7,793 sh	$29.70	−$231K	547,343
2025-09-26	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+17.2K sh	$6.11	+$105K	564,550
2025-09-26	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−17.2K sh	$28.85	−$496K	547,343
2025-09-26	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−17.2K sh	—	—	185,935
2025-08-27	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−7,426 sh	—	—	203,142
2025-08-27	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+7,426 sh	$6.11	+$45.4K	554,769
2025-08-27	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−7,426 sh	$25.01	−$186K	547,343
2025-08-26	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−17.6K sh	—	—	210,568
2025-08-26	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−17.6K sh	$24.96	−$439K	547,343
2025-08-26	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+17.6K sh	$6.11	+$107K	564,917
2025-08-20	SIONSionna Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−25K sh	$22.75	−$569K	547,343
2025-08-20	SIONSionna Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−25K sh	—	—	228,142
2025-08-20	SIONSionna Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+25K sh	$6.11	+$153K	572,343
2025-06-02	bluebird bio, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,867 sh	—	—	0
2025-02-06	SIONSionna Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+450K sh	—	—	450,252
2024-09-30	bluebird bio, Inc.A Award	Director	AAward	+37.4K sh	—	—	37,350
2024-06-20	bluebird bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+74.8K sh	—	—	74,775
2021-02-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+19K sh	—	—	19,000
2020-05-01	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+50K sh	—	—	50,000
2020-04-28	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+9,450 sh	—	—	9,450
2020-02-12	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+22.5K sh	—	—	22,500
2019-07-25	Sage Therapeutics, Inc.F Tax Payment	Chief Business Officer	FTax Payment	−1,088 sh	$161.38	−$176K	2,102

Recent filings

Accepted (ET)
Sep 184
Cloonan Michael0001704336-26-000005
SEC(opens sec.gov)
Jan 64
Cloonan Michael0001704336-26-000002
SEC(opens sec.gov)
Oct 224
Cloonan Michael0001704336-25-000008
SEC(opens sec.gov)
Oct 174
Cloonan Michael0001704336-25-000006
SEC(opens sec.gov)

Companies

Address

C/O SIONNA THERAPEUTICS, INC. 21 HICKORY DRIVE, SUITE 500

WALTHAM, MA, 02451